These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3260858)

  • 1. Influence of thyroid function on serum bone Gla protein.
    Yoneda M; Takatsuki K; Yamauchi K; Oiso Y; Kurokawa M; Kawakubo A; Izuchi K; Tanaka H; Kozawa O; Miura Y
    Endocrinol Jpn; 1988 Feb; 35(1):121-9. PubMed ID: 3260858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of assaying serum bone GLA protein level in patients with hyperthyroidism].
    Wang DS; Yin W; Wang WL
    Zhonghua Nei Ke Za Zhi; 1991 Jan; 30(1):40-3, 61-2. PubMed ID: 2032496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism.
    Garrel DR; Delmas PD; Malaval L; Tourniaire J
    J Clin Endocrinol Metab; 1986 May; 62(5):1052-5. PubMed ID: 3485649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bone Gla protein (BGP) during treatment of hyperthyroidism and hypothyroidism. A longitudinal study.
    Faber J; Perrild H; Johansen JS
    Horm Metab Res; 1991 Mar; 23(3):135-8. PubMed ID: 1864560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism.
    Sabuncu T; Aksoy N; Arikan E; Ugur B; Tasan E; Hatemi H
    Endocr Res; 2001; 27(1-2):203-13. PubMed ID: 11428712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein.
    Brixen K; Nielsen HK; Eriksen EF; Charles P; Mosekilde L
    Calcif Tissue Int; 1989 Feb; 44(2):93-8. PubMed ID: 2783876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.
    Kojima N; Sakata S; Nakamura S; Nagai K; Takuno H; Ogawa T; Matsui I; Sarui H; Miura K
    J Endocrinol Invest; 1992; 15(7):491-6. PubMed ID: 1447487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up.
    Coen G; Mazzaferro S; Bonucci E; Taggi F; Ballanti P; Bianchi AR; Donato G; Massimetti C; Smacchi A; Cinotti GA
    Kidney Int; 1985 Nov; 28(5):783-90. PubMed ID: 3878905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum bone Gla protein and urinary gamma-Gla as biochemical markers in primary hyperparathyroidism.
    Yoneda M; Takatsuki K; Oiso Y; Takano T; Kurokawa M; Ota A; Tomita A; Ohno T; Okano K; Kanazawa T
    Endocrinol Jpn; 1986 Feb; 33(1):89-94. PubMed ID: 3487445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein.
    Riggs BL; Tsai KS; Mann KG
    J Bone Miner Res; 1986 Dec; 1(6):539-42. PubMed ID: 3509744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
    Malluche HH; Faugere MC; Fanti P; Price PA
    Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
    Epstein S; Traberg H; Raja R; Poser J
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1253-6. PubMed ID: 3889031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in serum bone GLA protein with age and sex.
    Epstein S; Poser J; McClintock R; Johnston CC; Bryce G; Hui S
    Lancet; 1984 Feb; 1(8372):307-10. PubMed ID: 6141381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amino-terminal propeptide of type III procollagen in patients with hyperthyroidism or hypothyroidism during therapy.
    Kucharz EJ; Jurecka-Tuleja B; Jonderko G; Marcisz C
    Thyroid; 1994; 4(2):191-4. PubMed ID: 7920002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.
    Braclik M; Marcisz C; Giebel S; OrzeĊ‚ A
    Thyroid; 2008 May; 18(5):545-50. PubMed ID: 18466078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.
    Ismail F; Epstein S; Pacifici R; Droke D; Thomas SB; Avioli LV
    Calcif Tissue Int; 1986 Oct; 39(4):230-3. PubMed ID: 3098385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bone Gla protein (BGP) in primary hypothyroidism before and during treatment with thyroid hormones.
    Bergmann P; Dediste A; Demeester-Mirkine N; Deconinck I; Corvilain J
    Horm Metab Res; 1989 Jan; 21(1):47-8. PubMed ID: 2784402
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effects of levothyroxine replacement therapy on bone and mineral metabolism in patients with hypothyroidism].
    Chai R; Ye Z; Zhan Z; Liu W; Yu M; Liu Y
    Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):18-21. PubMed ID: 11798620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.